These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15987921)

  • 1. Gamma-hydroxybutyric acid.
    Snead OC; Gibson KM
    N Engl J Med; 2005 Jun; 352(26):2721-32. PubMed ID: 15987921
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
    Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA
    Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
    Carai MA; Quang LS; Atzeri S; Lobina C; Maccioni P; Orrù A; Gessa GL; Maher TJ; Colombo G
    Brain Res Brain Res Protoc; 2005 Jul; 15(2):75-8. PubMed ID: 15886053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GHB, GBL and 1,4-BD addiction.
    Brunt TM; van Amsterdam JG; van den Brink W
    Curr Pharm Des; 2014; 20(25):4076-85. PubMed ID: 24001290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of evidence leading to the prediction that 1,4-butanediol is not a carcinogen.
    Irwin RD
    J Appl Toxicol; 2006; 26(1):72-80. PubMed ID: 16193534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropharmacological profile of tetrahydrofuran in mice.
    Werawattanachai N; Towiwat P; Unchern S; Maher TJ
    Life Sci; 2007 Apr; 80(18):1656-63. PubMed ID: 17331547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol addiction: a serious health threat.
    Beck R; Matanović SM; Zibar L
    Arh Hig Rada Toksikol; 2019 Jun; 70(2):149-150. PubMed ID: 31246568
    [No Abstract]   [Full Text] [Related]  

  • 8. Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential?
    Bernasconi R; Mathivet P; Bischoff S; Marescaux C
    Trends Pharmacol Sci; 1999 Apr; 20(4):135-41. PubMed ID: 10322498
    [No Abstract]   [Full Text] [Related]  

  • 9. [Update on gamma-hydroxybutyric acid].
    García FB; Pedraza C; Navarro JF
    Rev Neurol; 2006 Jul 1-15; 43(1):39-48. PubMed ID: 16807871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abuse and therapeutic potential of gamma-hydroxybutyric acid.
    Galloway GP; Frederick-Osborne SL; Seymour R; Contini SE; Smith DE
    Alcohol; 2000 Apr; 20(3):263-9. PubMed ID: 10869868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP summary report on the metabolism, disposition, and toxicity of 1,4-butanediol (CAS No. 110-63-4).
    Irwin RD
    Toxic Rep Ser; 1996 May; (54):1-28, A1-8, B1-5. PubMed ID: 11803699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [GHB--dangerous, addictive and uncontrollable "party drug"].
    Persson SA; Eriksson A; Hallgren N; Eklund A; Berkowicz A; Druid H
    Lakartidningen; 2001 Sep; 98(38):4026-31, 4033-5. PubMed ID: 11602959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GHB, GBL and butanediol poisonings--a serious problem in Western Sweden].
    Knudsen K; Greter J; Verdicchio M; Cederquist T
    Lakartidningen; 2005 Nov 7-13; 102(45):3294-6, 3299. PubMed ID: 16342543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone.
    Lenz D; Rothschild MA; Kröner L
    Ther Drug Monit; 2008 Dec; 30(6):755-61. PubMed ID: 18824955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-methylpyrazole decreases 1,4-butanediol toxicity by blocking its in vivo biotransformation to gamma-hydroxybutyric acid.
    Quang LS; Desai MC; Shannon MW; Woolf AD; Maher TJ
    Ann N Y Acad Sci; 2004 Oct; 1025():528-37. PubMed ID: 15542758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies.
    Carter LP; Flores LR; Wu H; Chen W; Unzeitig AW; Coop A; France CP
    J Pharmacol Exp Ther; 2003 May; 305(2):668-74. PubMed ID: 12606639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-hydroxybutyric acid and its relevance in neurology.
    Benarroch EE
    Neurology; 2009 Jan; 72(3):282-6. PubMed ID: 19153376
    [No Abstract]   [Full Text] [Related]  

  • 18. High affinity binding site for gamma-hydroxybutyric acid in rat brain.
    Maitre M; Rumigny JF; Benavides J; Bourguignon JJ; Wermuth CG; Cash C; Mandel P
    Adv Biochem Psychopharmacol; 1983; 37():441-53. PubMed ID: 6314770
    [No Abstract]   [Full Text] [Related]  

  • 19. A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand.
    Wu H; Zink N; Carter LP; Mehta AK; Hernandez RJ; Ticku MK; Lamb R; France CP; Coop A
    J Pharmacol Exp Ther; 2003 May; 305(2):675-9. PubMed ID: 12606613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors, neurotransmitters and drug responses.
    Snyder SH
    N Engl J Med; 1979 Mar; 300(9):465-72. PubMed ID: 32488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.